Skip to content

Cipla: Sharp improvement in margins not likely to sustain

While the respiratory portfolio remains a significant part of the US portfolio, the peptides portfolio is a key watch in the near to medium term.

Read More

​ While the respiratory portfolio remains a significant part of the US portfolio, the peptides portfolio is a key watch in the near to medium term. While the respiratory portfolio remains a significant part of the US portfolio, the peptides portfolio is a key watch in the near to medium term.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish